Summary
Symberix Inc
Founded in 2013
Description
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberixs scientific founder, Matthew Redinbo, PhD, was the first to demonstrate the feasibility of therapeutically controlling the mammalian microbiome with small-molecule symbiotic drugs. Based on this breakthrough research, the company is advancing a first-in-class approach to improve the treatment of serious lower gastrointestinal (GI) diseases as well as mitigate the debilitating lower GI side effects associated with various cancer, pain and immunosuppressive therapies. Symberixs internal team and scientific/clinical/business advisors have a deep understanding of the microbiome as well as extensive drug discovery, clinical development and commercial biopharma experience. Our vision: Safe and effective pharmaceutical control of the microbiome.
Strengths
- Revenue growth is more steady than the industry average
- Since Symberix Inc was founded, the company has grown faster than the industry average
Weaknesses
- Symberix Inc has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
Annual Revenue
Symberix Inc's annual revenue
$996000
Based on Kona Equity data
-
Revenue per employee
$199200
-
Variance of revenue growth
0.13
-
Annual revenue growth since founding
$90545
-
Revenue growth rate from first known quarter to current
-79.6%
Employee Count
5 employees
-
Employee growth rate from first known quarter to current
-78.8%
G Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Symberix Inc
- SIC: 283; 28
- NAICS: 541; 5417
See similar companies
-
By City Durham
-
By State NC Small companies in NC
-
Firmographic data G Score of 2 Founded in 2013 SIC: 283 SIC: 28 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Symberix Inc's headquarters are located at 4819 Emperor Blvd., #400 Durham, NC 27703.
Symberix Inc's official website is symberix.net
Symberix Inc's annual revenue is $996.0 K.
Symberix Inc's SIC: 283; 28
Symberix Inc's NAICS: 541; 5417.
Symberix Inc has 5 employees